Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Short term Debt (2016 - 2021)

Historic Short term Debt for International Stem Cell (ISCO) over the last 13 years, with Q1 2021 value amounting to $219000.0.

  • International Stem Cell's Short term Debt changed N/A to $219000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $219000.0, marking a year-over-year change of. This contributed to the annual value of $141000.0 for FY2020, which is N/A changed from last year.
  • As of Q1 2021, International Stem Cell's Short term Debt stood at $219000.0.
  • International Stem Cell's Short term Debt's 5-year high stood at $2.8 million during Q3 2017, with a 5-year trough of $57000.0 in Q3 2020.
  • Over the past 5 years, International Stem Cell's median Short term Debt value was $1.3 million (recorded in 2017), while the average stood at $1.3 million.
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 1047692.31% in 2017, then crashed by 9691.56% in 2020.
  • International Stem Cell's Short term Debt (Quarter) stood at $2.8 million in 2017, then tumbled by 36.55% to $1.7 million in 2018, then increased by 5.9% to $1.8 million in 2019, then tumbled by 92.37% to $141000.0 in 2020, then surged by 55.32% to $219000.0 in 2021.
  • Its Short term Debt stands at $219000.0 for Q1 2021, versus $141000.0 for Q4 2020 and $57000.0 for Q3 2020.